| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Wobble Genomics Ltd Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing. Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing. Its innovative Level-Up biochemical technology enhances the detection of low-abundance RNA sequences, allowing scientists to capture all unique full-length RNA sequences in any sample. Paired with its TAMA bioinformatic technology, Wobble optimises the identification of low-level signals, using RNA biology to drive deeper insights from sequencing data Type: | 0 | 0 | 0 | 26 |
 |  Procavea Biotech Procavea Biotech is on a mission to solve the problem of delivering RNA-based drugs to non-liver tissues. At Procavea we're developing nonviral protein cages as carriers for the delivery of RNA Therapeutics to specific tissues in the body. Protein Engineering and RNA Delivery Type: | 0 | 0 | 0 | 1 |
 | Mironid® Limited Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our lead programme is in the area of rare genetic kidney disease. Type: | 1 | 0 | 1 | 17 |
 | EPITERNA Creating more time that matters for pets and people We are a growing team of ambitious scientists, engineers, veterinarians and doctors based in Europe and we are passionate about life extending science. We understand that our mission will not be simple or quick, but we are determined to create more time that matters for people and their pets. Ageing is one of the greatest challenges of our time. As the major risk factor for diseases and functional decline, it is at the root of the most devastating health problems we face. Science has demonstrated that we can slow the ageing … | 0 | 0 | 0 | 6 |
 |  Mysthera Therapeutics Multilineage immune modulation. The next chapter in autoimmune diseases. Mysthera is a preclinical stage biotech start-up focused on developing first-in class, oral therapeutics to treat major unmet needs in autoimmune diseases. Our unique approach has potential to transform patient lives in a number of disease settings including glomerulonephritis, rheumatoid arthritis and inflammatory bowel disease. We are first to develop PIM kinase inhibitors as therapeutics for multi-lineage immune cell driven autoimmune diseases. The team are experts in PIM kinase and immunology. Mysthera was founded by Forty51 Ventures in Europe’s pharma/biotech hub, Basel, in Switzerland in early 2023. biotech, kinase inhibitors, autoimmune … Type: | 0 | 0 | 0 | 3 |
 | Mallia Therapeutics Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Type: | 1 | 0 | 1 | 3 |
 | NK:IO Cancer treatment reimagined. Unlocking the potential of human Natural Killer cells. Type: | 0 | 0 | 0 | 14 |
 | Adamas Biotech Srl Advancing the state-of-the-art in nature-based healthcare solutions Adamas Biotech is a clinical stage company pioneering the development of nutraceutical-based prophylactic and therapeutic solutions for a range of clinical and wellness indications. The company is specialized in the development of bioactive molecules derived from botanicals, in particular, green tea catechins. Its initial pipeline is based on 100% natural formulations of green tea purified compounds, which are under development for use in cancer prevention, anti-aging, wound care and sports medicine. Type: | 0 | 0 | 0 | N/A |
 | Amara Therapeutics Revolutionising Pelvic Health Amara Therapeutics is a digital therapeutics company that develops innovative digital health solutions for patients suffering from pelvic health conditions. Type: | 0 | 0 | 0 | 8 |
 | Adaptyv Bio Next-generation protein engineering Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building a next-gen protein foundry to allow you to synthesize and test any protein you design. Type: | 0 | 0 | 0 | 17 |
 | CaSRevolution A new hope for patients affected by Alzheimer’s disease CaSRevolution is a research company specialized in devising innovative therapies for neurodegeneration diseases We have discovered a new mechanism that explains the progression of Alzheimer’s Disease and identified a potential therapeutic approach biotech, neurodegeneration, startup, and alzheimer Type: | 0 | 0 | 0 | 6 |
 | Delta Life Science We make rapid, highly sensitive and low-cost biosensing accessible for everyone. Enabling more. For less. It's our mission to make label-free, multiplexed biosensing accessible to all. Assay Developers need to validate next-gen biomarker panels for more accurate diagnostics. Academic Researchers need to extract more data from precious samples to guide their studies. Pharma Scientists need to speed up drug development by collecting extensive data from a wide range of samples. The Merits Of Label-Free Biosensing? Label-free biosensing enables real-time, direct detection without the need for tagging target molecules. This revolutionary approach benefits a wide range of applications, from studying molecular … Type: | 0 | 0 | 0 | 37 |
 | Resurrect Bio Helping crops defeat disease We are a plant biotech start-up, based in London. We're working on how to improve the immune system of crop species. Crops were bred over generations by plant breeders to improve key traits such as yield, height or drought-tolerance, but sometimes inadvertently lost key immune resistance genes. Additionally, modern monocultures are static in evolution, but the pests and pathogens that threaten them are not. Plant diseases are constantly evolving new ways of defeating the R-genes in crops. Climate change is making matters worse – diseases are spreading to new locations, meaning the disease spectrum farmers are … | 0 | 0 | 0 | 9 |
 | pHion Therapeutics Developing Next Generation mRNA Vaccines pHion Therapeutics is a UK based biotech delivering ground-breaking nucleic acid vaccines and therapeutics. The proprietary RALA peptide-based drug delivery system is based on a sequence of 30 amino acids which condenses anionic cargo (RNA and DNA), irrespective of size, into nanoparticles. These nanoparticles are highly efficient at cellular entry with 100% release from the endosomes. When used in vaccines, the RALA platform can deliver multiple anionic molecules, such as mRNA, in a stealth-like way by evading detection. This generates both a potent antigen-specific CD8+ T-cell response that is ideal for therapeutic vaccines, and a … Type: | 0 | 0 | 0 | 11 |
 | Tharimmune, Inc. Biotech company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. Tharimmune, Inc. (Nasdaq: THAR) is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or "uncontrollable itching" in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors. Tharimmune has a license agreement with OmniAb, … Type: | 0 | 0 | 0 | 6 |
 | inbiome Radically accelerating human healthcare By combining machine learning with advanced chemistry, inBiome enables microbiology labs over the world to rapidly and easily identify bacteria in a wide range of clinical sample types, including complex microbiota. Even uncultivable- and antibiotics treated species are detected. Current applications include replacing traditional culture in ICU’s for more accurate, same day results, infection control, gut flora analysis and various r&d applications for healthcare, pharmacy and food industies. Promising new applications currently undergoing clinical trials include IBD and Sepsis dagnostics and preventive screening. Molecular Diagnostics and Bacterial infections Type: | 1 | 0 | 1 | 22 |
 | VisusNano Ltd VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for YAG laser capsulotomy after surgery, our device has the potential to revolutionise cataract surgery in both the human and veterinary markets. Type: | 0 | 0 | 0 | 6 |
 | CanSense Innovations in blood testing for cancer At CanSense we utilise cutting-edge data analytics and machine learning to maximise the performance of our blood test aimed at triaging patients at high risk of cancer. Cancer Diagnostics, AI analytics, Colorectal cancer, Early detection, and Spectroscopy Type: | 0 | 0 | 0 | 18 |
 | GeneHub Empowering patients to bridge rare disease research and trials through a revolutionary clinico-genomic databank. Backed by VCs and an IUK government grant, GeneHub is building the world's first patient-controlled, clinico-genomic databank to bridge rare disease research and clinical trials. GeneHub enhances patient visibility and engagement by elevating patients into verified, zero-party data partners equipped with longitudinal real-world data from primary and secondary care. To ensure privacy, patients must consent to researchers analysing their anonymised clinico-genomic data in secure, on-demand, clean rooms. Patients actively engaging with researchers benefit from free advanced diagnostics such as DNA and mRNA sequencing, accelerating clinical trial … Type: | 0 | 0 | 0 | 7 |
 | Napo Therapeutics We cultivate reciprocal relationships with anyone who crosses our path We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals. Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions. Our name reflects our story: The Napo River crosses the territories of the Amazon where the Croton lechleri tree grows – the plant from which we extract the sap that contains a precious active ingredient. We are investigating an innovative and first-in-class drug thanks to the … Type: | 0 | 0 | 0 | 8 |
 | Aida Oncology Helping cancer patients to get the right drugs Cancer is a disease with millions of variations where even the most effective current treatment protocols will not work for many patients. We at AIDA believe that modern high-performance computing and machine learning combined with cutting-edge gene reading tools can fast forward personalized cancer therapy and improve treatment options for cancer patients. Type: | 0 | 0 | 0 | 7 |
 | Orexa B.V. Developing a medicine that increases food intake Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake. Its lead compound ORE-001 is a proprietary oral formulation, based on a well known anesthetic. The company has started its first phase 2a study in the Prevention of Post-Operative Ileus. Furthermore it is in preparation for phase 2a studies in Anorexia and Cachexia. With these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, … Type: | 0 | 0 | 0 | 1 |
 | ACTIMED THERAPEUTICS Innovation in Cachexia ACTIMED THERAPEUTICS LTD is a company based out of the United Kingdom. Type: | 0 | 0 | 0 | 14 |
 | FindMeCure Bringing research closer to patients Whether we help patients find treatments in research through FindMeCure's search platform or we help the industry plan successful clinical trials through TrialHub, we have one mission: Bringing Research Closer to Patients. FindMeCure's clinical trial search engine is used on a daily basis by people searching for clinical trials and so far we have served close to a million people worldwide. One of the things we learned along the way is that today's study planning process is often inefficient and causes unmet patient needs resulting in unmet recruitment targets and higher budgets. To address this … Type: | 0 | 0 | 0 | 28 |
 | MPC Therapeutics Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies. At MPC Therapeutics, we are convinced that mitochondria, the small organelles at the core of the cell's metabolism, represent untapped therapeutic targets. Headquartered in Switzerland, our startup is focused on cellular rejuvenation to improve the performance of cell therapies and treat degenerative pathologies. Our novel approach uses proprietary first-in-class small molecules that specifically target mitochondria to trigger metabolic reprogramming. Visit our website for more info. Longevity, Mitochondria, Cellular rejuvenation, Immunotherapy, and CAR T cell therapy Type: | 0 | 0 | 0 | 6 |
 | Infinant Health We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease. Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to … Type: | 2 | 1 | 1 | 16 |
 | Hudson River Biotechnology We provide solutions to enhance the functions of plants using CRISPR plant breeding and smart delivery systems Hudson River Biotechnology delivers technologies that are needed to meet the challenges of our food systems. In the face of a changing climate, the need to achieve sustainability goals and a growing population, current agricultural practices are becoming untenable. Only new technological approaches will transform agriculture into a sustainable and efficient activity. Hudson River Biotechnology has developed technologies to enhance the functions of plants using CRISPR and deliver agrochemical inputs efficiently through targeted, nanotechnology-based systems. By providing these technologies to its partners, HRB … Type: | 4 | 1 | 3 | 34 |
 | Relief srl Stop leaking without stopping your life Relief is developing an innovative magnetically-controlled medical device against stress urinary incontinence, already patented and tested on humans. Our solution is uni-sex, easy to use, minimally invasive, fast to insert/remove, invisible, and able to drastically improve the quality of life of millions of people worldwide who can no longer live a normal daily life with their families. urinary incontinence, engineering, artificial sphincter, innovative solution, and medical device Type: | 1 | 0 | 0 | 3 |
 | Aurion Biotech We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. Type: | 1 | 1 | 0 | 72 |
 |  IntBiotechnologies.com IntBiotechnologies is an International Bio-medical Products Supplier and Consultant company founded by a research scientist, expert in clinical diagnostic and an international consultant. The company was born in recognition of the two principal needs: Laboratory services are an essential component of health services, requiring constant update and strengthening for improved clinical diagnostic, better testing, epidemiological surveillance, bio-medical research activities. The current and future needs of the biotechnology companies to provide to their customers an end users tested and approved customized products. IntBiotechnologies, LLC offers services to U.S. government agencies, state and local health departments, world wide state and governments, academic … | 0 | 0 | 0 | 1 |
 | Ibex Medical Analytics Pioneering AI-based cancer diagnostics in pathology Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our GalenTM platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Galen is … Type: | 17 | 4 | 16 | 105 |
 | Prosoma Prosoma Digital Healthcare provides comprehensive solutions that improve the quality of life for cancer patients. 💡 We are a global, interdisciplinary team of world-class scientists, psychologists, and engineers, as well as experienced and passionate new-tech entrepreneurs. We were brought together to deliver digital healthcare solutions at the forefront of innovation for oncology. 💡 In constant search for new solutions, our mission is to improve existing mental health care in the field by bridging the respective gaps and addressing emerging challenges and needs of stakeholders across the system. 💡 We believe that the future of cancer-related mental health care is digital, … Type: | 3 | 0 | 1 | 30 |
 | Mirai Medical Precision Cancer Therapy - - MedTech Innovator '23 A culture of innovation, a passion for excellence At Mirai Medical, we are passionate about developing technology that greatly improves cancer outcomes and enhances patient experiences. Following intensive research and development, Mirai Medical was formed from a team with over 50 combined years of experience in the areas of pulsed electrical fields, electroporation for cancer, immunotherapy and medical device development to address critical unmet challenges in cancer treatment. We have developed unique IP that allows for outpatient delivery of ePORE therapy which greatly facilitates the ease and improves the outcome of cancer … Type: | 2 | 0 | 0 | 20 |
 | Renovos Biologics Limited Next-generation regenerative medicine solutions, pioneering use of synthetic nanoclay gels for tissue regeneration. Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton. Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite. Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Cell Based Assays, and Orthopaedics Type: | 0 | 0 | 0 | 11 |
 | Overseed Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, … Type: | 2 | 2 | 0 | 18 |
 | InnaVirVax InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the … Type: | 0 | 0 | 0 | 0 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … Type: | 8 | 4 | 1 | 26 |
 | Unibiome (Peer To Peer Probiotics) Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification Type: | 0 | 0 | 0 | 1 |
 | Machine Bio Machine Bio is a biotech company offering unique protein synthesis and purification solutions. Machine Bio is an early stage biotechnology company developing a novel, proprietary protein synthesis platform that can produce pure protein from a DNA template in a easy-to-use, single-step, 4 hour process. Proteins are broadly used in many industries and Machine Bio’s platform has a range of possible applications across drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing. Protein Synthesis, Protein Purification, Contract Protein Expression, R&D, Startup, Cell-Free Systems, and Supported Lipid Bilayer Type: | 1 | 1 | 0 | 3 |
 | CITRAGE, Stratégies nutritionnelles innovantes dédiées à la santé des séniors [Automatic translation follows] CITRAGE is a research and development company in the field of health nutrition. It develops in partnership with the University of Paris Descartes food supplements and oral nutritional supplements intended for people over 50 years old. The two main products are made up of 100% L-Citrulline, a non-protein amino acid, having a direct action on muscle protein synthesis, thus optimizing the use of other amino acids and allowing better maintenance of muscles. - MyoCIT is a food supplement to preserve muscle capital during aging, it is intended for young seniors in prevention of age-related muscle wasting (causing … Type: | 0 | 0 | 0 | 7 |
 | Theranexus Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous. Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease. Type: | 12 | 7 | 5 | 14 |
 | Cyrebro Neurosignals [Automatic translation follows] myBrain Tech becomes CYREBRO NEUROSIGNALS myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to extract informative insight to better understand the impact of their product or service on their users' brains. Our team of neuroscientists and data scientists develops algorithms and automated dashboards to analyze and interpret human EEG and behavioral data in real life context, and create strategic AI Model. myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to extract informative insight to better understand the impact of their product or services on their users' brains. … Type: | 30 | 15 | 17 | 13 |
 | MED'INN'Pharma A clinic-ready biotech developing human cell-derived secretome drugs to cure inflammation-related pathologies Med’Inn’Pharma (MIP) is a clinic-ready Biotech company that was founded in 2017 as a spin-off from the French blood bank establishment (EFS) and of the French National Institute of Health (INSERM). MIP is a pioneer in developing a new class disease modifying therapies dedicated to resolve pathologic inflammation in a wide range of degenerative diseases and conditions. Our founders are world leaders in immunology and inflammation-resolution, and have developed a patent protected process to harness bioactive molecules from physiologically conditioned human cells into a stable biologic drug product. … Type: | 4 | 3 | 1 | 5 |
 | Cellaven Cell culture automation, simple and affordable, for R&D laboratories Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only). biotechnology, automated cell culture, and 3D cell culture Type: | 9 | 9 | 0 | 4 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … Tags: FrenchTech120 FrenchTech2030 Type: | 49 | 24 | 31 | 166 |
 | YSOPIA Bioscience Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota Type: | 4 | 2 | 3 | 4 |
 | GATACA SYSTEMS Gataca Systems builds and integrates modular systems to perform the most demanding imaging and photo-manipulation techniques. Thus, we can integrate all the following techniques on new and existing microscope : Ring TIRF, FRAP, Photo-activation, Photo-ablation, Micropatterning, Single Molecule Super-Resolution, Live Confocal Super-Resolution, SPIM, Multichannel Detection (up to 4 channels), triple output high-power laser launches. All combinations can be done in a simultaneous manner. For more info : info@gataca-systems.fr www.gataca-systems.com spinning disk, TIRF microscopy, super resolution microscopy, FRAP microscopy, metamorph software, and Scientific cameras Type: | 0 | 0 | 0 | 6 |
 | EuropaBio - the European Association for Bioindustries Innovative biotechnology, benefiting people and planet. EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. Type: | 39 | 10 | 36 | 31 |
 | Northwestern University Clinical and Translational Sciences (NUCATS) Institute Accelerating Your Clinical & Translational Research Discoveries to Improve Human Health The NUCATS Institute is an integral link in Northwestern University’s clinical and translational research enterprise, accelerating translational innovation by providing research teams with consultative resources and expertise. The Institute is a member of the Clinical and Translational Science Award (CTSA) consortium, an initiative led by the National Institutes of Health (NIH). clinical and translational research, clinical trials, research navigation, research collaborations, drug, device and diagnostic development, research study support, community and practice engagement, data and informatics services, and education and career development Type: | 8 | 1 | 5 | 17 |
 | Accelerated Cure Project for Multiple Sclerosis We work in collaboration to improve the health, healthcare, and quality-of-life for people affected by MS. The Accelerated Cure Project for Multiple Sclerosis (ACP) is a non-profit organization whose mission is to accelerate research efforts to improve diagnosis, optimize treatment, and to cure Multiple Sclerosis (MS). ACP believes that research is the only way to greatly improve the outlook for people with MS. The organization promotes scientific collaboration and accelerates research by rapidly and cost-effectively providing researchers with data and biospecimens they need to explore novel research ideas that can lead to better care for people with MS. Its strategic … Type: | 5 | 1 | 5 | 21 |
 | California Life Sciences (CLS) California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization. California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this … Type: | 38 | 6 | 35 | 11 |
 | Global Liver Institute It all starts with a patient Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease. GLI holds Platinum Transparency with Candid/GuideStar, is a member of the National Health … Type: | 21 | 2 | 18 | 31 |
 | AIS Congress The major mAb Event in France ! The Antibody Industrial Symposium jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector.The AIS is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more! mAbs, Immunotherapy, Industry, Innovation, Research, drugdiscovery, networking, and B2B Type: | 21 | 5 | 19 | 1 |
 | Corasso [Automatic translation follows] Support and inform people affected by cancer, or rare cancer, of the head or neck Head and neck cancers are little known and yet they are the 4th most common cancer location in France. For young patients or people with a healthy lifestyle, diagnosis is often late, limiting the chances of recovery and requiring heavy treatments. When remission is possible, patients must also often learn to live with serious functional and aesthetic after-effects. Corasso is a young association of patients with cancer, or rare cancers, of the head or neck. Its missions: - Provide support in the … Type: | 25 | 2 | 19 | 9 |
 | Biopredic International Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products … Type: | 3 | 2 | 1 | 27 |
 | Amplitude Laser Leading international manufacturer of ultrafast lasers for scientific, medical and industrial applications since 2001. Amplitude is a leading manufacturer of ultrafast lasers for scientific, medical and industrial applications. From ultrafast industrial fiber lasers to petawatt-class high intensity lasers, Amplitude is focused on helping its customers with advanced solutions. Amplitude offers a unique, distinct and large product portfolio: diode-pumped ultrafast solid-state lasers, ultra-high energy Ti:Sapphire ultrafast lasers and a full line of high energy solid state laser products. With three manufacturing locations in Bordeaux and Paris (France), and Milpitas, U.S.A., and an extensive network of support offices, more than 400 employees … Type: | 15 | 3 | 13 | 309 |
 | Inits INITS is a consultancy company specialized in Quality Management and Pharmaceutical Development. We provide tailored consulting services including expert advice with hands-on operational execution Founded in 2013 by Amel HADRI, INITS has experienced reasonable and controlled year-to-year growth. INITS today comprises highly qualified and experienced full-time employees who have significant pharmaceutical industry experience. Type: | 8 | 1 | 0 | 21 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 26 | 14 | 11 | 206 |
 | Porsolt - Preclinical CRO Scientist-to-Scientist 🔬 Porsolt is a long-established preclinical CRO, accredited by AAALAC and fully GLP compliant. 👨🏻🔬 With our Scientist-to-Scientist approach we support you at every step of the preclinical development process, providing the best scientific advice and offering tailored solutions to meet your needs. ✔️ We have a recognized international reputation for in vitro, ex vivo, and in vivo expertise in physiopathological models, customized procedures, histology, biomarkers, and tailored solutions for discovering treatments in over 10 different therapeutic areas. ✔️ We also offer services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in … Type: | 4 | 1 | 4 | 87 |
 | In-Cell-Art In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of solutions (DNA/RNA based vaccines or therapeutics) treating acquired or inherited diseases using patented bioinspired synthetic delivery systems (named Nanotaxi®) consisting of different chemical families (lipids, polymers). Its founder and research team, which includes a Nobel Laureate, have developed this unique intellectual property expertise and know-how based on 20 years of research in the field of supramolecular nucleic acids transfection agents. The vaccines and therapeutics developed by In-Cell-Art have been validated by numerous studies using infectious disease models (HIV, Flu, Dengue, dust mite, mycobacterium abscessus), therapeutic cancer models … Type: | 0 | 0 | 0 | 1 |
 | EXTRACTIS [Automatic translation follows] Experts in #plant #biorefinery, #innovative #process #engineering, #extraction, #processing, #production, #scale-up EXTRACTIS is a service provider specializing in the field of extraction, fractionation and chemistry of plant biomass for the development of new innovative products/processes. 2 main activities: Research and Development under contract with processes adapted to the markets and in line with the issues and constraints of our customers on all types of plant raw materials, co-products or fractions using in particular innovative technologies (Ultrasound, Membrane Electrodialysis, reactive extrusion, subcritical water, etc.) Transfer and shaping: the service platform dedicated to the design of turnkey projects from … Type: | 21 | 4 | 6 | 12 |
 | Linear Diagnostics Limited Linear Diagnostics utilises Linear Dichroism as a platform to develop point of care tests for infectious diseases. Linear Diagnostics Limited (LDL) is a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. The technology provides significant advantages over the current state of the art allowing a more rapid detection of multiple targets using a single simple reagent. Such a solution has applications in a number of high-value sectors including health, food, defence and security. LDL has also established development partnerships with a number of end … Type: | 0 | 0 | 0 | 6 |
 | Santero Therapeutics A start-up biotech active in the field of antibiotics discovery. Santero Therapeutics is a start-up biotech active in the field of antibiotics discovery. We are developing first-in-class, novel generations of drugs to fight multiple resistant pathogens Type: | 0 | 0 | 0 | 17 |
 | Linio Biotech Ltd Linio Biotech is a biotechnology platform company developing novel tissue product Tience® that regenerates healthy skin. Type: | 0 | 0 | 0 | N/A |
 | Kinarus Therapeutics Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases. Kinarus Therapeutics (SIX:KNRS) is a clinical-stage pharmaceutical company focused on bringing novel, patient-focused treatments for viral, respiratory, and ophthalmic diseases. Kinarus was incorporated in Basel, Switzerland in 2017. Our lead drug candidate is an oral combination of a clinical-stage P38 mitogen activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, and a second drug, together enabling an oral, long-term effective treatment. Kinarus has launched a large Phase 2 clinical trial in hospitalized Covid-19 patients with the aim to reduce mortality and duration of hospital stay. The … Type: | 0 | 0 | 0 | 5 |
 | Topadur Pharma AG Disruptive Therapies for Aging Diseases Topadur Pharma AG is a Swiss biopharmaceutical start-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R&D Pharma. Topadur’s vision is to improve patients’ quality of life by providing highly effective and safe drugs for unmet medical conditions. Topadur has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases like chronic … Type: | 0 | 0 | 0 | 15 |
 | Galventa AG Empower people to perform every day at their best – from the very moment they wake up. Galventa stands for galenic innovation. Our mission is to improve the efficacy of nutraceuticals through better delivery technologies that feature unique release profiles & best-in-class bioavailability. Our technologies are patented, clinically proven, published, and serve as platforms that are applicable in OTC/Nutra. Galventa showcases its technologies under its own consumer brand “B・SYNC®” with products that improve the hallmarks of sleep, mental health and rejuvenation. pharmaceutical technology, Release Profile, Micro Pellets, Sleep, Wake-up, social jet lag, and Nutraceuticals Type: | 0 | 0 | 0 | 6 |
 | SEED Biosciences One Click, One Cell We are SEED Biosciences, a spinoff from the Swiss Federal Institute of Technology (EPFL). We make DispenCell. One click, one cell. DISPENCELL is an automated laboratory instrument designed for fast, easy, and gentle single cell isolation. DISPENCELL is a pipetting robot designed to be compact, gentle, and intuitive, yet compliant with the most stringent regulatory standards. Designed by scientists for scientists, DISPENCELL has been thought to quickly integrate your lab routine in a plug-and-play approach. Flexible and effortless, DISPENCELL operates equally under sterile conditions in a culture hood, or on a simple benchtop. Its unique technology … Type: | 1 | 1 | 0 | 18 |
 | iCellate Medical AB Cancer profiling for precision oncology and early cancer detection iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing. Cancer Diagnostics, Circulating Tumor Cells (CTC), Liquid Biopsy, Next Generation Sequencing, CDx, Hereditary Cancer, Early Detection, Cancer, and Solid Tumors Type: | 0 | 0 | 0 | 10 |
 | iOnctura Developing precision small molecules to combat hard-to-treat tumors. iOnctura is a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers with precision oral small molecules that target cancers in novel ways. The bold new treatments extend lives and improve healthspans, changing the outlook for patients and their families. Two therapeutic candidates have progressed into mid-stage clinical development: roginolisib is the first allosteric modulator of PI3Kδ and cambritaxestat is the only autotaxin inhibitor in clinical development to treat cancer. oncology, drug development, and clinical development Type: | 6 | 2 | 4 | 27 |
 | Rosa Biotech Biosensing. Reimagined. Rosa Biotech is an AI-driven biosensing and diagnostics company based in Bristol. Our mission is to provide outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology. We have developed a novel sensing platform that leverages the rapid and precise approach honed over millions of years in the olfactory systems of mammals. By using machine learning we are capable of discriminating between complex biological samples and are able to predict commercial and clinical outcomes. Biosensing, Diagnostics, AI, Machine learning, Medicines manufacturing, Industrial biotechnology, Biotechnology, Biodesign, Chemistry, Protein design, Peptide design, Sensing, and Detection Type: | 0 | 0 | 0 | 3 |
 | AstriVax Committed to address real-world challenges in vaccinology AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad … Type: | 0 | 0 | 0 | 37 |
 | Lentitek Enabling the next generation of medicines Lentitek is developing solutions to help amazing therapies get to more people. Gene therapies, and gene-modified cell therapies such as CAR-T are proving themselves as incredible life changing and life saving therapies. However they face an issue with the production yield of the viral vector. Lentitek is developing solutions to improve the viral yield by 10 fold and beyond. This will help these developers reduce production costs and allow these amazing therapies get into more people who really need it! Type: | 1 | 0 | 1 | 7 |
 | Anavo Therapeutics BV UNLOCKING THE PHOSPHATASE TARGET CLASS Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures. drug discovery, phospatase biology, and oncology Type: | 0 | 0 | 0 | 24 |
 | MUVON Therapeutics AG Regain control with personalized muscle regeneration MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life. Type: | 0 | 0 | 0 | 22 |
 | PNEUMAGEN LIMITED Pneumagen is treating infectious diseases by targeting the human glycome. PNEUMAGEN LIMITED is a biotechnology company based out of St. Andrews, Scotland | 0 | 0 | 0 | 10 |
 | Halo Therapeutics The DeepTech Health Company The DeepTech Health Company Biotechnology, Virology, Antivirals, Small Molecule Drugs, Drug Development, and Pharmaceuticals Type: | 4 | 0 | 4 | 4 |
 | Oniria Therapeutics A shift in cancer treatment methodology makes a world of difference. A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme. Biotechnology, cancer, cell … Type: | 4 | 0 | 3 | 16 |
 | ARTHEx Biotech Developing microRNA modulators for diseases with unmet medical needs ARTHEx Biotech is a spin-off biotech company from the University of Valencia (Spain) focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical needs. ARTHEx has developed its proprietary platform that allows fast and flexible development of investigational miR-modulating oligonucleotides that are designed to enter relevant tissues in pharmacological quantities, in order to treat diseases in which microRNAs play a key role. The first investigational product from this platform is ATX-01, an antimiR in development for Myotonic Dystrophy Type 1 (DM1). DM1 … | 0 | 0 | 0 | 28 |
 | smartbax Developing novel multi-targeted antibiotics with extraordinary potency against multi-drug resistant bacteria. smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Type: | 2 | 0 | 2 | 4 |
 | Anocca Engineered Immunity Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely … Type: | 6 | 0 | 6 | 115 |
 | ZiO Health Proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes ZiO Health is a medical technology & digital health company that has developed proprietary pocket sized technology, bringing lab testing to the point of use for various single-point and continuous monitoring applications. The proprietary biosensor technology has been used to develop an AI-driven hand-held point-of-care device for therapeutic drug monitoring & precision dosing to improve patient drug treatment outcomes. It facilitates a proactive approach to dosing life saving medications by providing immediate data on the drug concentration in blood. The concentration result is inserted into ZiO Healths … Type: | 6 | 0 | 2 | 11 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 45 |
 | HEARTNET | Techstars '23 Solving fake and falsified medicines. Solving the $200billion epidemic of fake and falsified medicine Trade in counterfeited and falsified drugs has reached over 200 Billion dollars and the WHO warns that this problem is going to get worse. Hundreds of thousands of deaths are caused by faked and falsified drugs in Africa every year. We help Pharmaceuticals comply with track and trace to fight fake and falsified drugs. Type: | 1 | 0 | 1 | 3 |
 | EpiCapture Limited Discovery and development of liquid biopsy tests for early detection and prognostic assessment of cancer. EpiCapture's mission is to improve the care of cancer patients through the development of accurate, non-invasive, urine tests to identify aggressive cancers. EpiCapture-prostate is the company's first product to progress to commercialisation. In vitro diagnostics | 0 | 0 | 0 | 1 |
 | LiberaBio Addressing "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells. LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, and Cytotoxics Type: | 2 | 1 | 2 | 11 |
 | Genomtec SA Molecular diagnosis everywhere, at the right time and for the right price. Genomtec is a MedTech company specializing in the development of advanced technologies in the field of genetic diagnostics. The company's flagship project is the Genomtec ID mobile diagnostic system, which allows for fast and precise molecular analysis outside the laboratory environment without the need to involve qualified laboratory personnel. The company has EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, which simultaneously detects the presence of the most common respiratory tract infections. The solution uses microfluidic technology and proprietary patented SNAAT® isothermal technology. The Genomtec technology … Type: | 0 | 0 | 0 | 26 |
 | NUCAPS 🔬 New encapsulation technology for the industrial development of Nanocapsules and Biocapsules 💊 Green Nanotechnology NUCAPS@ is a consortium comprised by two Pharmaceutical companies (Laboratorios Cinfa and IDIFARMA), a Food Technological Center (CNTA) and the University of Navarra. T his consortium has developed new solutions based on the use of Food proteins (GRAS) as casein, zein or soya for the oral delivery and controlled release of drugs/actives and/or microorganisms. Nanotechnology, Encapsulation, Nanoencapsulation, Microencapsulation, Food, Nutrition, Cosmetic, Farmaceutic, and Pharmaceutical Type: | 10 | 2 | 3 | 19 |
 | SynaptixBio Ltd. Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, … Type: | 2 | 0 | 2 | 5 |
 | Phialogics - The immune tolerance company Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases. Our immune checkpoint activators protect patient’s organ tissue. Unique approach : - Potential for BEST-in-class super agonist against immune-mediated tissue damage - High selectivity for active T-cells - Proof of concept in relevant human in vitro models and mouse model of disease Type: | 1 | 0 | 1 | 4 |
 | PureIMS 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery PureIMS is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops®. The focus is on the treatment of systemic and respiratory diseases with significant unmet medical need. The company’s leadership team consists of seasoned life sciences executives who bring long-lasting and complementary experience in leading drug development, addressing applicable scientific issues and pursuing commercial and business development & licensing opportunities. They obtained their experience in leading positions with mid-size and top-5 global … Type: | 0 | 0 | 0 | 10 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 22 |
 | Alia Therapeutics On-target gene therapies Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications. Type: | 0 | 0 | 0 | 15 |
 | Moolec Science Science in Food Ingredients We are a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. Our mission is to create unique food ingredients by engineering plants with animal protein genes. Moolec’s technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Our technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company’s product portfolio and pipeline leverages the agronomic efficiency of broadly … Type: | 3 | 1 | 2 | 21 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 1 | 0 | 1 | 53 |
 | Positrigo Imaging Everyone Dementia is a major problem in our aging societies costing nearly a trillion USD worldwide per year. Treatments are on the horizon, but an affordable and widely available diagnostic technique is still missing. Positrigo’s brain positron emission tomography system offers functional brain imaging to everyone at a fraction of today’s cost. Medtech, Brain PET, Functional Imaging, Alzheimer's disease, Nuclear Medicine, and Start up Type: | 7 | 0 | 7 | 21 |
 | Ariceum Therapeutics Developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following … Type: | 1 | 1 | 1 | 38 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 8 | 1 | 1 | 66 |
 | Zetta Genomics Ltd The Genome Optimised Data Store: Enabling healthcare transformation using big data technology Zetta Genomics unleashes the power of precision medicine – shaping the future of genomic data to transform the health of millions of people around the world. bioinformatics, genomics, genomic medicine, precision medicine, and biomedical research Type: | 1 | 0 | 1 | 32 |
 | NunaBio Limited Synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies. DNA, Custom DNA, Gene Synthesis, Synthetic Biology, Biotechnology, and DNA Synthesis Type: | 4 | 0 | 3 | 22 |
Startup